Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

School of Public Health: Anis Emilia

Researchers / חוקרים

 Last updated December 2021 - School of Public Health

List of Publications

(1) Gorelik Y, Anis E, Edelstein M. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. Lancet Reg Health Eur 2022;12.

(2) Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. New Engl J Med 2021;385(23):2140-2149.

(3) Singer SR, Angulo FJ, Swerdlow DL, McLaughlin JM, Hazan I, Ginish N, et al. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine 2021;42.

(4) Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015–2016. Vaccine 2021;39(48):7101-7107.

(5) Perepliotchikov Y, Ziv-Baran T, Hindiyeh M, Manor Y, Sofer D, Moran-Gilad J, et al. Inferring numbers of wild poliovirus excretors using quantitative environmental surveillance. Vaccines 2021;9(8).

(6) Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, et al. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. Eur J Epidemiol 2021;36(7):727-734.

(7) Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021;397(10287):1819-1829.

(8) Gozlan Y, Bar-Or I, Volnowitz H, Asulin E, Rich R, Anis E, et al. Lessons from intensified surveillance of viral hepatitis a, Israel, 2017 and 2018. Eurosurveillance 2021;26(6).

(9) Anis E, Haas EJ, Indenbaum V, Singer SR, Warshavsky B, Rishpon S, et al. A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19. J Infect 2021.

(10) Langsam D, Anis E, Haas EJ, Gosinov R, Yechezkel M, Grotto I, et al. Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis. Vaccine 2020;38(12):2700-2706.

(11) Tur-Sinai A, Gur-Arie R, Davidovitch N, Kopel E, Glazer Y, Anis E, et al. Vaccination uptake and income inequalities within a mass vaccination campaign. Isr J Health Policy Res 2019;8(1).

(12) Bercovich S, Anis E, Kassem E, Rubinstein U, Ephros M, Cohen D, et al. Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry. Vaccine 2019;37(21):2791-2796.

(13) Salama M, Amitai Z, Lustig Y, Mor Z, Weiberger M, Chowers M, et al. Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases. Travel Med Infect Dis 2019;28:41-45.

(14) Lustig Y, Gosinov R, Zuckerman N, Glazer Y, Orshan L, Sofer D, et al. Epidemiologic and phylogenetic analysis of the 2018 west Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I. Eurosurveillance 2019;24(1).

(15) Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Reemergence of human brucellosis in Israel. Isr Med Assoc J 2019;21(1):10-12.

(16) Elran B, Yaari S, Glazer Y, Honovich M, Grotto I, Anis E. Parents' perceptions of childhood immunization in Israel: Information and concerns. Vaccine 2018;36(52):8062-8068.

(17) Adamker G, Holzer T, Karakis I, Amitay M, Anis E, Singer SR, et al. Prediction of Shigellosis outcomes in Israel using machine learning classifiers. Epidemiol Infect 2018;146(11):1445-1451.

(18) Anis E, Moerman L, Ginsberg G, Karakis I, Slater PE, Warshavsky B, et al. Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel? J Public Health Policy 2018;39(3):304-317.

(19) Rosenberg Danziger C, Anis E, Gordon E-, Grotto I, Danon YL. Reintroducing OPV in Israel on the journey to global polio eradication – Estimation at a low rate of contraindicated population. Vaccine 2018;36(26):3717-3720.

(20) Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Association between human brucellosis and adverse pregnancy outcome: a cross-sectional population-based study. Eur J Clin Microbiol Infect Dis 2018;37(5):883-888.

(21) Dadon Y, Haas EJ, Kaliner E, Anis E, Singer SR, Atiya-Nasagi Y, et al. Outbreak of human leptospirosis linked to contaminated water bodies in Northern Israel, June to August 2018. Eurosurveillance 2018;23(38).

(22) Muhsen K, Anis E, Rubinstein U, Kassem E, Goren S, Shulman LM, et al. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011–2015: a case–control study. Clin Microbiol Infect 2018;24(1):53-59.

(23) Lustig Y, Kaufman Z, Mendelson E, Orshan L, Anis E, Glazer Y, et al. Spatial distribution of West Nile virus in humans and mosquitoes in Israel, 2000–2014. Int J Infect Dis 2017;64:20-26.

(24) Indenbaum V, Hübschen JM, Stein-Zamir C, Mendelson E, Sofer D, Hindiyeh M, et al. Ongoing mumps outbreak in Israel, January to August 2017. Eurosurveillance 2017;22(35).

(25) Gozlan Y, Bar-Or I, Rakovsky A, Savion M, Amitai Z, Sheffer R, et al. Ongoing hepatitis a among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 – June 2017. Eurosurveillance 2017;22(29).

(26) Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Isr J Health Policy Res 2017;6(1).

(27) Tasher D, Kopel E, Anis E, Grossman Z, Somekh E. Causality assessment of serious neurologic adverse events following the bOPV national vaccination campaign in Israel. Isr Med Assoc J 2016;18(10):590-593.

(28) Glatman-Freedman A, Kaufman Z, Kopel E, Bassal R, Taran D, Valinsky L, et al. Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting. J Infect 2016;73(2):99-106.

(29) Tasher D, Rahav G, Levine H, Sofer D, Linder N, Anis E, et al. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine 2016;34(3):299-301.

(30) Brosh-Nissimov T, Poles L, Kassirer M, Singer R, Kaliner E, Shriki DD, et al. Preparing for imported ebola cases in israel, 2014 to 2015. Eurosurveillance 2015;20(44).

(31) Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, et al. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Eurosurveillance 2015;20(42).

(32) Kaliner E, Kopel E, Anis E, Mendelson E, Moran-Gilad J, Shulman LM, et al. The Israeli public health response to wild poliovirus importation. Lancet Infect Dis 2015;15(10):1236-1242.

(33) Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis 2015;211(11):1800-1812.

(34) Levine H, Kopel E, Anis E, Givon-Lavi N, Dagan R. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012. Eurosurveillance 2015;20(7).

(35) Kopel E, Grotto I, Grossman T, Haklai Z, Marva E, Anis E. Long-term predictors of recurrent laboratory-confirmed giardiasis: A 10-year national surveillance study. J Pediatric Infect Dis Soc 2014;3(4):343-346.

(36) Shulman LM, Mendelson E, Anis E, Bassal R, Gdalevich M, Hindiyeh M, et al. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013. J Infect Dis 2014;210:S304-S314.

(37) Elinav H, Hershko-Klement A, Valinsky L, Jaffe J, Wiseman A, Shimon H, et al. Pregnancy-associated listeriosis: Clinical characteristics and geospatial analysis of a 10-year period in Israel. Clin Infect Dis 2014;59(7):953-961.

(38) Gandacu D, Glazer Y, Anis E, Karakis I, Warshavsky B, Slater P, et al. Resurgence of cutaneous leishmaniasis in Israel, 2001-2012. Emerg Infect Dis 2014;20(10):1605-1611.

(39) Anis E, Grotto I, Mendelson E, Bin H, Orshan L, Gandacu D, et al. West Nile fever in Israel: The reemergence of an endemic disease. J Infect 2014;68(2):170-175.

(40) Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, et al. Molecular epidemiology of Legionnaires' disease in Israel. Clin Microbiol Infect 2014;20(7):690-696.

(41) Anis E, Grotto I, Moerman L, Kaliner E, Warshavsky B, Slater PE, et al. Rubella in Israel after the MMR vaccine: Elimination or containment? J Public Health Policy 2013;34(2):288-301.

(42) Avidor B, Turner D, Mor Z, Chalom S, Riesenberg K, Shahar E, et al. Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy. PLoS ONE 2013;8(3).

(43) Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y. Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis. Isr J Health Policy Res 2013;2(1).

(44) Anis E, Kopel E, Singer SR, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into israel, 2013. Eurosurveillance 2013;18(38).

(45) Levy Y, Anis E, Kaliner E, Grotto I, Danon YL. Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel. Vaccine 2012;30(47):6632-6635.

(46) Moran-Gilad J, Lazarovitch T, Mentasti M, Harrison T, Weinberger M, Mordish Y, et al. Huhumidifier-associated paediatric legionnaires' disease, Israel, February 2012. Eurosurveillance 2012;17(41).

(47) Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: Are two doses enough? Epidemiol Infect 2012;140(3):439-446.

(48) Engelhard D, Bromberg M, Averbuch D, Tenenbaum A, Goldmann D, Kunin M, et al. Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal infl uenza among children, Israel. Emerg Infect Dis 2011;17(9):1740-1743.

(49) Anis E, Leventhal A, Grotto I, Gandacu D, Warshavsky B, Shimshony A, et al. Recent trends in human brucellosis in Israel. Isr Med Assoc J 2011;13(6):359-362.

(50) Levy I, Mor Z, Anis E, Maayan S, Leshem E, Pollack S, et al. Men who have sex with men, risk behavior, and HIV infection: Integrative analysis of clinical, epidemiological, and laboratory databases. Clin Infect Dis 2011;52(11):1363-1370.

(51) Muhsen K, Shohat T, Aboudy Y, Mendelson E, Algor N, Anis E, et al. Sero-prevalence of mumps antibodies in subpopulations subsequently affected: By a large scale mumps epidemic in Israel. Vaccine 2011;29(22):3878-3882.

(52) Anis E, Leventhal A, Slater PE, Arbeli Y, Sivan Y, Berlovitz Y, et al. A cluster of deaths following influenza vaccination, Israel, 2006. J Public Health Policy 2010;31(3):318-323.

(53) Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B, et al. Measles in a highly vaccinated society: The 2007-08 outbreak in Israel. J Infect 2009;59(4):252-258.

(54) Anis E, Leventhal A, Slater PE, Shinar E, Yahalom V, Smetana Z, et al. Smallpox revaccination of 21 000 first responders in Israel: lessons learned. Int J Infect Dis 2009;13(3):403-409.

(55) Balicer RD, Anis E, Goldmann D, Dahan D, Singer R, Grotto I. Influenza A/H1N1 in Israel--clinical and epidemiological characteristics. Harefuah 2009;148(11):738-742, 795.

(56) Pezzoli L, Elson R, Little CL, Yip H, Fisher I, Yishai R, et al. Packed with Salmonella - Investigation of an international outbreak of Salmonella Senftenberg infection linked to contamination of prepacked Basil in 2007. Foodborne Pathog Dis 2008;5(5):661-668.

(57) Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J Hepatol 2007;47(4):514-520.

(58) Moerman L, Leventhal A, Slater PE, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. Isr Med Assoc J 2006;8(5):308-311.

(59) Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. J Am Med Assoc 2005;294(2):202-210.

(60) Ben-Ami R, Siegman-Igra Y, Anis E, Brook GJ, Pitlik S, Dan M, et al. Malaria in travelers returning from short organized tours to holiday resorts in Mombassa, Kenya. Isr Med Assoc J 2005;7(6):364-367.

(61) Sidi G, Davidovitch N, Balicer RD, Anis E, Grotto I, Schwartz E. Tickborne relapsing fever in Israel. Emerg Infect Dis 2005;11(11):1784-1786.

(62) Anis E, Pener H, Goldmann D, Leventhal A. The reemergence of malaria in Israel? Harefuah 2004;143(11):815-819.

(63) Ben-Simon GJ, Peiss M, Anis E, Nakra T, Luski A, Spierer A. Spectacle use and reduced unaided vision in third grade students: A comparative study in different educational settings. Clin Exp Optom 2004;87(3):175-179.

(64) Green MS, Anis E, Gandacu D, Grotto I. The fall and rise of gonorrhoea incidence in Israel: An international phenomenon? Sex Transm Infect 2003;79(2):116-118.

(65) Slater PE, Anis E, Leventhal A. Communicable Disease Control: An introductory course for MPH students. Public Health Rev 2002;30(1-4):327-338.

(66) Slater PE, Anis E, Leventhal A. Preparation for an outbreak of smallpox in Israel. Isr Med Assoc J 2002;4(7):507-512.

(67) Green MS, Aharonowitz G, Shohat T, Levine R, Anis E, Slater PE. The changing epidemiology of viral hepatitis A in Israel. Isr Med Assoc J 2001;3(5):347-351.

(68) Slater PE, Leventhal A, Anis E. The elimination of smallpox from Israel. Isr Med Assoc J 2001;3(1):71-72.

(69) Anis E, Leventhal A, Elkana Y, Wilamowski A, Pener H. Cutaneous leishmaniasis in Israel in the era of changing environment. Public Health Rev 2001;29(1):37-47.

(70) Anis E, Leventhal A, Roitman M, Slater PE. Introduction of routine hepatitis A immunization in Israel--the first in the world. Harefuah 2000;138(3):177-180, 272.

(71) Aharonowitz G, Koton S, Segal S, Anis E, Green MS. Epidemiological characteristics of spotted fever in Israel over 26 years. Clin Infect Dis 1999;29(5):1321-1322.

(72) Slater PE, Anis E, Leventhal A. Measles control in Israel: A decade of the two-dose policy. Public Health Rev 1999;27(1-3):235-241.

(73) Slater PE, Anis E, Leventhal A. The control of mumps in Israel. Eur J Epidemiol 1999;15(8):765-767.

(74) Dagan R, Fraser D, Roitman M, Slater P, Anis E, Ashkenazi S, et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. Vaccine 1999;17(2):134-141.

(75) Ostroi P, Anis E, Green MS. Shigellosis in Israel - Update 1995. Public Health Rev 1996;24(3-4):213-225.

(76) Slater PE, Roitman M, Leventhal A, Anis E. Control of rubella in Israel: Progress and challenge. Public Health Rev 1996;24(2):183-192.

(77) Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. Lancet 1995;346(8976):660-662.

(78) Slater PE, Roitman M, Anis E. Failure of mass chemoprophylaxis to control hyperendemic meningococcal disease. Public Health Rev 1995;23(4):367-369.